ABSTRACT So far, the optical mapping of cardiac electrical signals using voltage-sensitive fluorescent dyes has only been performed in experimental studies because these dyes are not yet approved for clinical use. It was recently reported that the well-known and widely used fluorescent dye indocyanine green (ICG), which has FDA approval, exhibits voltage sensitivity in various tissues, thus raising hopes that electrical activity could be optically mapped in the clinic. The aim of this study was to explore the possibility of using ICG to monitor cardiac electrical activity. Optical mapping experiments were performed on Langendorff rabbit hearts stained with ICG and perfused with electromechanical uncouplers. The residual contraction force and electrical action potentials were recorded simultaneously. Our research confirms that ICG is a voltage-sensitive dye with a dual-component (fast and slow) response to membrane potential changes. The fast component of the optical signal (OS) can have opposite polarities in different parts of the fluorescence spectrum. In contrast, the polarity of the slow component remains the same throughout the entire spectrum. Separating the OS into these components revealed two different voltage-sensitivity mechanisms for ICG. The fast component of the OS appears to be electrochromic in nature, whereas the slow component may arise from the redistribution of the dye molecules within or around the membrane. Both components quite accurately track the time of electrical signal propagation, but only the fast component is suitable for estimating the shape and duration of action potentials. Because ICG has voltage-sensitive properties in the entire heart, we suggest that it can be used to monitor cardiac electrical behavior in the clinic.
INTRODUCTION
Optical methods have been used in heart electrophysiological studies for over 30 years (1) . The development of signal registration techniques combined with improved fluorescent dye properties has allowed the wide use of these methods for cardiac experimental research under both control and pathological conditions. These methods provide precise spatial and temporal evaluations of electrical signals and have significant advantages over other currently used methods for electrical signal registration in the clinic. However, optical recording of cardiac electrical activity is still not used for clinical diagnosis, largely because of the lack of voltage-sensitive dyes (VSDs) that are approved for use in humans. Treger and colleagues (2) recently published an article in the Biophysical Journal reporting that the well-known and widely used fluorescent dye indocyanine green (ICG), which has FDA approval, exhibits a voltagesensitive pattern in various tissues (including cultured heart cells), thus raising hopes that electrical activity could be optically mapped in the clinic.
Transmembrane electrical activity and action potentials (APs) are recorded with the use of high-speed VSDs. Styryl compounds are among the most popular VSDs and exhibit blue/green or red/NIR fluorescence excitation and emission spectra (3, 4) . After the dye accumulates in cell membranes, a change in the membrane potential is believed to evoke rapid transformation of the dye molecules or changes in the chromophore charge that alter the fluorescence properties. The response time of these compounds is less than a millisecond, and thus the electrical signals of various biological cells can be recorded without distortion.
Treger and colleagues (2) showed that the ICG dye exhibits a relatively slow change in fluorescence intensity in response to a changing membrane potential compared with that observed with typical fast potentiometric dyes, and the voltage-sensitive reaction may have two separate components with time constants of 4 and 63 ms. Compared with the microelectrode-recorded electric APs, the recorded optical APs (OAPs) are slow and shifted in time. These results encouraged us to carefully explore the use of ICG to monitor cardiac electrical activity in the entire heart.
The absorption and emission spectra of ICG are known to be broad (5) . Therefore, in our experiments, we used light from a variety of LEDs to obtain excitation wavelengths ranging from 530 nm to 780 nm. In agreement with the report by Treger et al. (2) , we found that the voltage-sensitive optical signal (OS) of the ICG dye has a small amplitude (~1%) and has two components with different time constants for the voltage-sensitive reaction.
These components appear to originate from different mechanisms, but these mechanisms were not reported in the earlier study. To the best of our knowledge, this is the first report to describe potential mechanisms underlying the voltage-sensitive ICG fluorescence in the entire heart. We believe that our results are relevant because they could help open the door for optical recording of cardiac electrical activity in the clinic.
MATERIALS AND METHODS

General
All experimental procedures involving animals conformed to the European Community guiding principles and were approved by the State Food and Veterinary Service of the Republic of Lithuania and the Ethics Committee of the Lithuanian University of Health Sciences.
The techniques and procedures used for the simultaneous measurement of fluorescence and electrical signals from whole-heart preparations have been described previously (6, 7) . In brief, experiments were performed on rabbits (New Zealand White) weighing 3.9 5 0.2 kg (n ¼ 12). For the initial sedation of the animal, xylazine (10 mg/kg) containing heparin (1000 U/kg) was administered via subcutaneous injection. After 20 min, the animal was further anesthetized with an intravenous injection of ketamine (10 mg/kg). The chest was then opened and the heart was quickly excised, cannulated through the aorta, mounted on a Langendorff perfusion system with a constant pressure of~80 mmHg, and perfused with oxygenated (100% O 2 ) Tyrode's solution (in mmol/L: 135 NaCl, 5.4 KCl, 1.8 CaCl 2 , 0.9 MgCl 2 , 0.33 NaH 2 PO 4 , 10 glucose, and 10 HEPES; pH 7.4) at 37 C 5 0.5 C. The coronary flow rate was 34.7 5 2.3 mL/min. After equilibration, the perfusion was switched to recirculation mode. To minimize motion, the posterior wall of the heart was pressed against an elastic mesh and 20 mmol/L blebbistatin was added to the perfusate. The heart was stained by injecting a 10-mL slow bolus of the fluorescent indocyanine dye (50 mmol/L) into the perfusate. 2,3-Butanedione monoxime (BDM, 5 mmol/L) was also added to the perfusate to eliminate post-blebbistatin contraction.
The hearts were paced at a 300-ms period from the endocardial surface of the left ventricle (LV) via a bipolar silver electrode with a 2-ms impulse at twice the diastolic threshold. In some experiments, stimulation was also performed from the right atrium and epicardium with automatic atrial-toendocardial-to-epicardial pacing switchovers for OS and AP recordings. For atrial and epicardial stimulation, bipolar hook electrodes were embedded in the right atrium and the LV epicardial surface, respectively.
Optical measurements
Collimated LEDs (Thorlabs) with a variety of wavelengths (530 nm, 590 nm, 660 nm, 735 nm, and 780 nm (filtered at 775-785 nm)) were used for excitation of the dye. Emission was collected using band-pass filters for various wavelengths (680/30 nm, 700/40 nm, 725/40 nm, 747/ 33 nm, 775/46 nm, 780/10 nm, 794/32 nm, 819/44 nm, 840/12 nm, and 870/10 nm) and the long-pass filters (720 nm and 800 nm). The emission filters were mounted in a motorized filter wheel (with 16 positions for filters) (8MRU-1WA; Standa Ltd., Lithuania). The emitted fluorescence signals were recorded with a cooled (À100 C) fast 14-bit EMCCD camera (iXon EMþ DU-860; Andor Technology, Ireland) equipped with a 50-mm focal length objective (Navitar). The filter wheel was located in front of the objective. The emission filters for each excitation wavelength were consecutively replaced for each movie recording. Optical movies were acquired at a sampling rate of 500 Hz with a resolution of 128 Â 128 pixels using imaging software (Andor SOLIS x-3467). To mark the time of electrical stimulation in the optical recording, a small LED that generated 2-ms pulses in synchrony with the pacing cycle was placed in the camera's field of view. The anterior surface of the LV (20 Â 20 mm) was imaged, i.e., the calculated pixel size was 20 mm/128 pix ¼ 156 mm/pix.
The optical movies were preprocessed with the use of ImageJ software. The OSs for analysis were taken from an area of 5 Â 5 pixels. Background fluorescence was subtracted from every frame of the recording. To decrease noise, 16 consecutively recorded OSs over time were averaged. The averaged signal was then normalized using the background fluorescence to obtain the fractional change of voltage-sensitive fluorescence signal.
Detection and evaluation of ICG OS components
The spectra of the VSD may shift as a function of the membrane potential (3). Thus, the voltage-dependent fractional fluorescence recorded at various wavelengths may have different polarities. It can be presumed that using a ratio of two OSs with opposite polarities will increase the overall signal required and reduce the influence of a signal whose polarity is similar at different wavelengths. Logically, an opposite procedure, such as multiplication of the OSs, could reveal a signal with stable polarity and thus reduce the influence of the signal with different polarities. Both procedures can help one distinguish the individual components from the whole OS by reducing the impact of the second component. Therefore, in this study, we used a ratio to determine the fast component (OS f ) of the OS, and performed multiplication to identify the slow component (OS s ) of the OS. The sum of these components constitutes the whole OS. To quantitatively evaluate each component in the OS, we normalized the OS f and OS s , and then calculated the sum of these components using the following equation:
where b is the partition coefficient (0 < b < 1). b was varied to fit this sum of OS. This allowed the proportion of each component in the total OS to be evaluated.
Voltage-sensitive reaction time constant of OS s
The time constant of OS s for the response to changes in the membrane potential was determined in two steps. First, the OS f was fitted to OS s using an exponential smoothing procedure. Exponential smoothing is also known as exponential weighted moving, i.e., a function that operates on the geometric progression principle, analogously to an exponential function. This formulation is also known as Brown's simple exponential smoothing (8) .
Here, the procedure was applied to OS f , and OS s was calculated using the equation
where x t is the current observation of OS f , s t-1 is the previous smoothed statistic, and a is the smoothing factor (0 < a < 1). The OS f was fitted to OS s by varying a. Second, an exponential smoothing procedure was applied to a rectangular step-like pulse using the determined value of a. The obtained curve was also fitted to an exponent whose time constant was defined as the OS s voltage-sensitive reaction time constant.
Electrophysiology
The procedure for obtaining microelectrode recordings of APs deep inside the LV wall has been described previously (7) . In brief, to record the cellular transmembrane potential, we used glass microelectrodes filled with 3 mol/L KCl (resistance from 35 to 55 MU) to impale the myocardial wall from the epicardial surface. The impalement depth was controlled by a hydraulic micromanipulator and special detectors (Millitron, Measuring Probes 1310)
Biophysical Journal 110(3) 723-732 with an accuracy of %0.1 mm. The depth detectors were directly connected to the holders for the glass microelectrode. The signal from these detectors was recorded simultaneously with the electrical APs. The zero point for depth measurements was set when the microelectrodes reached the epicardial surface. The microelectrodes were connected to the input stage of a high-impedance amplifier (MEZ-7101; Nihon Kohden, Japan). The amplified signals were digitized by a 16-channel PowerLab system (ADInstruments, Oxford, UK) at a frequency of 20 kHz. The data were recorded using LabChart8 Pro software (ADInstruments). The contraction of the heart was recorded with a linear force-displacement transducer (Harvard Apparatus).
Chemicals
For the experiments, we used (5)-blebbistatin from Cayman Chemical, and BDM, ICG (Cardiogreen), diltiazem, and pinacidil from Sigma-Aldrich (St. Louis, MO). A stock solution of the ICG dye (1 mg/mL in H 2 O) was freshly prepared before every experiment and diluted to a final concentration of 50 mmol/L in 10 mL of Tyrode's solution containing blebbistatin. Water-insoluble compounds were initially dissolved in dimethyl sulfoxide or ethanol to make stock solutions, which were then diluted. The final concentration of the solvent was < 0.1%, which did not affect the fluorescence measurements.
Data analysis
LabChart8
Pro software was used to analyze the activation time (i.e., the time interval from the stimulus to the dV/dt max value of an AP, and the time to 50% of the depolarization of an OAP) and the upstroke duration (i.e., the time interval between 10% and 90% depolarization) of APs. The duration of the signals was calculated at 50% and 90% of the repolarization. OAP maps of the activation time (evaluated at 50% of the depolarization level), amplitude, and duration were constructed from optical movies using custom Scroll 1.16 software developed by Dr. S. Mironov (University of Michigan).
Data are given as the mean 5 SEM. The significance of differences was evaluated using a two-tailed t-test with the significance level set at p < 0.05.
RESULTS AND DISCUSSION
Isolation of the ICG OS in the heart
A previous report by Treger and colleagues (2) demonstrated a voltage-dependent fluorescence change (of~1.9% of the baseline fluorescence) in neural and cardiomyocyte cultures from neonatal rats stained by ICG when the excitation wavelength (l ex ) was 780-800 nm and the emission wavelength (l em ) was >810 nm. In this study, we operated with similar excitation and emission wavelengths (l ex ¼ 780 nm and l em > 800 nm, referred to as 780/800 nm) to investigate whether it is possible to observe such small voltage-sensitive signals in the whole heart with an ICG fluorescent dye.
The whole heart usually maintains some motion even after administration of the contraction-uncoupling drug blebbistatin (see below). Here, we clearly demonstrate that the shape of the OS recorded at 780/800 wavelengths was not typical of cardiac APs ( Fig. 1 A, gray line) . The OS obtained with the ICG dye in this spectral range had slower kinetics and a longer duration than those of the OAP recorded using the common fast-response voltage-sensitive NIR dyes (7) . It could be suggested that this slow shape of the OS resulted from the influence of residual cardiac contraction, which may have occurred because the amplitude of the fluorescence signal was low. The fractional change in fluorescence (DF/F) was 1.02% 5 0.09% (n ¼ 12). In such a case, even a small amount of motion may markedly distort the voltage-sensitive OS.
To verify that the OS follows the membrane potential changes and does not reflect a motion artifact, the magnitude of the heart contraction that remained after the administration of 20 mmol/L blebbistatin was recorded simultaneously with the OS. Fig. 1 A shows the overlapped original records of OSs (solid) and contractions (dotted). Despite the presence of blebbistatin in the superfused solution, contraction still clearly occurred (gray dots). Consequently, the OS obtained under such conditions has two humps (gray line in Fig. 1 A) . The second hump of the ICG fluorescence signal coincides almost exactly with the recorded contraction, which indicates that the motion artifact distorts and prolongs the OS. The contraction of the heart markedly diminished (red dots) only after another blocker (e.g., BDM, 5 mmol/L) was added to the superfusate, at which point the shape of the OS became more uniform (red line). The nearly complete disappearance of contractions after the administration of BDM and blebbistatin confirms that the observed increase in fluorescence with ICG likely is not caused by heart motion. Moreover, the amplitude of the ICG OS that was recorded in the presence of both contraction blockers was not only of the same polarity but also was quite uniform over most of the mapping area (Fig. 1, B and C) . These data also support the conclusion that the impact of contraction on the OS is low. If contraction had affected the resulting signal, the polarity and/or shape in distinct parts of the myocardium would have been different. Thus, to minimize the impact of heart contraction, all further recordings of ICG OSs were performed in the presence of both blockers.
In some experiments, the calcium antagonist diltiazem, which eliminates both contraction and Ca 2þ transients, was used to demonstrate that the ICG OS in these experiments was not caused by a change in the Ca 2þ transient. The administration of this drug in the presence of both blebbistatin and BDM had no additional impact on the ICG OS (data not shown). Thus, we concluded that the OS obtained from the ICG fluorescence is not caused by contraction and/or Ca 2þ transients, but in fact reflects changes in the electrical potential.
The emission/excitation ratiometric procedure is commonly used in optical mapping to reduce motion artifacts (9,10) because the signals generated by cardiac motion have the same polarity at all spectral wavelengths. In principle, the ratio of two OSs cannot completely eliminate the motion artifact because of the displacement of a contracting heart. As a result, a ratiometric signal from the moving heart consists of a mixture of OSs generated along the imaged trajectory. Therefore, the ratiometric measurement can only attenuate the motion artifacts and is beneficial when the heart contraction is modest (9) . In this study, we used the ratiometric procedure to discriminate two components of the OS: one with different DF/F fluorescence polarities in various regions of the spectrum, and one with the same polarity throughout the entire spectrum. Additionally, this procedure helped us to distinguish the fast component (see below) from the ICG OS of the rabbit whole-heart preparation when its contraction was fully blocked. Accordingly, the procedure used to obtain the derivative signals was appropriate.
Dependence of the ICG OS on the excitation and emission wavelengths
The fluorescence intensity of ICG increases when the dye molecules bind to proteins or lipids. The bound dye remains effective for a long time, but unbound ICG dye is unstable in saline solutions, where sedimentation may occur rapidly. For this reason, ICG accumulates in cell membranes. Because it has a negative charge, ICG responds to changes in the membrane potential, thus altering the fluorescence intensity. ICG has broad absorption and emission spectra, which are highly dependent on the concentration of the dye and its environment. Absorption occurs from 600 to 900 nm, and emission occurs from 700 to 950 nm (5) .
We also investigated the dependence of the ICG OS on the excitation (l ex ) and emission (l em ) wavelengths. For this purpose, we used different wavelengths of l ex (530 nm, 590 nm, 660 nm, 735 nm, and 780 nm), and collected l em through various long-pass and/or band-pass filters (see Materials and Methods). Fig. 2 shows the signals obtained using atrial pacing and the characteristic combinations of excitation and emission wavelengths. The signals obtained for all recorded combinations in response to stimulation from the atrial, endocardial, and epicardial surfaces are presented in Figs. S1-S3, respectively, in the Supporting Material. These data show that the fluorescent ICG dye could be used under various experimental conditions. As expected, at l ex ¼ 530 nm, the recorded fluorescence change was small relative to the noise (Fig. 2 A; see also Fig. S1 ). Therefore, the ICG OSs that resulted from excitation with green light (530 nm) were not further analyzed. The OSs that were evoked by the other excitation wavelengths used in this study were positive, negative, or had a biphasic shape depending on the emission spectra (see Fig. S1 ). Therefore, it is tempting to speculate that these signals are composed of two components, which could have different kinetics and spectral properties. Because the ICG OS has a small amplitude, it is desirable to use a long-pass emission filter, which collects the fluorescence signal from a wider range of the spectrum and thus improves the signal/noise ratio. A positive signal with a rapid increase in fluorescence, which reflects the depolarization phase of the OAP, was recorded at 590/720 nm and 590/800 nm (Fig. 2, B and E, respectively, yellow). The biphasic OS was obtained at 660/720 nm (Fig. 2 C, red) . It contains a small, short, positive peak followed by a negative wave, which is similar to the signals obtained at 660/800 nm, 735/800 nm, and 780/ 800 nm (Fig. 2, F-H, red, cherry, and brown, respectively) . Thus, signals with positive phases appear at 590/720 nm, 590/800 nm, and 660/720 nm. All of the OSs obtained at 660/800 nm, 735/800 nm, and 780/800 nm are negative. Hence, the use of different combinations of excitation and emission wavelengths revealed that the OS that was recorded at the characteristic wavelengths of the dye, i.e., l ex ¼ 780 nm and l em > 800 nm, has two independent (fast and slow) components (see description below), possibly caused by different mechanisms.
To distinguish the two components of the obtained OS and identify possible mechanisms of the ICG fluorescence change in the heart, we calculated the ratios (see Materials and Methods) of the OS records obtained at 590/720 nm and 660/720 nm with respect to the OS acquired at 780/ 800 nm (i.e., OS 590/720 /OS 780/800 (yellow) and OS 660/720 / OS 780/800 (red) in Fig. 2 D, respectively) . The signal of these ratios resembles a typical OAP with a characteristic fast upstroke, plateau phase, and repolarization. The OS 660/720 / OS 780/800 ratio is less noisy than the OS 590/720 /OS 780/800 ratio. Furthermore, 660-nm excitation has advantages over 590-nm excitation for experimental and clinical studies because the longer wavelength penetrates deeper into the tissue and is less absorbed by hemoglobin in blood-perfused preparations. This benefit greatly increases the potential relevance of a ratiometric ICG measurement (l ex with 660 nm and 780 nm) for optical measurements in a bloodperfused heart because at longer wavelengths (>650 nm), both scattering and absorption (largely due to hemoglobin) are dramatically reduced. Therefore, OSs at 660/720 nm and 780/800 nm were used for the detailed evaluation of ICG voltage sensitivity. Fig. 3 A shows the normalized OS obtained at 780/800 nm (red), the ratio OS 660/720 /OS 780/800 (termed the fast component, OS f , magenta), and the electrical AP (black) recorded using a glass microelectrode in the mid-myocardial cells (at an average depth of 1.5 5 0.7 mm from epicardium; n ¼ 6). The experimental curves presented in Fig. 3 A show that OS f correlates with the electrical AP in terms of the upstroke and duration; in contrast, for the whole OS 780/800 , both parameters are increased.
ICG OS-forming components
The OSs at 660/720 nm and 780/800 nm were multiplied with each other to identify the slow component (see Materials and Methods). The OS 780/800 (red) and its fast (magenta) and slow (gray) components are presented in Fig. 3 B. From Eq. 1, OS f and OS s were shown to constitute respectively 35.95% 5 0.84% and 64.05% 5 0.84% (n ¼ 12) of the total OS 780/800 , on average.
To estimate the temporal characteristics (i.e., the reaction delay constant) of the slow part of the OS, which reflects the kinetics of the voltage-sensitive response of ICG, we used exponential smoothing (Eq. 2), which follows the potential changes via exponential delay. The fitting was performed until the shape of the smoothed OS f signal became similar to that of the OS s (compare the dashed and gray curves in Fig. 3 C) . The time constant measured for OS s formation was 33.58 5 2.5 ms (n ¼ 12) (see Materials and Methods). Fig. 4 shows the OSs that were obtained experimentally or calculated using the fitting. The signals are composed of two components, which can be discriminated by the characteristics of the fluorescence spectra using the band-pass filters for the emission collection (see Materials and Methods).
The fast component of the OS can be obtained using short wavelengths for l em , whereas the slow component is detectable with the longer wavelengths (i.e., l em > 800 nm) and does not depend on the excitation light. Additionally, these data show that the OS s at all excitation and emission wavelengths is negative. Meanwhile, OS f can be positive or negative depending on the l ex and l em wavelengths. The DF/F values (in percent) given in the insets of Fig. 4 provide insights into the changes in the ratio of the OS f (magenta) versus the OS s (gray) components that compose the OS. These changes depend on the excitation and/or emission wavelengths. For the excitation at 590 nm and 600 nm, the OS f was always positive independently of the l em wavelength used in this study. However, when it was excited with the 780 nm wavelength, this component became negative. Importantly, when we applied the 735 nm (cherry) wavelength for excitation, the OS f obtained at the emission wavelengths at 780 nm and 794 nm was positive, the OS f at 819 nm was around zero, and the OS f at 840 nm and 870 nm was negative. Similar data were obtained in six separate experiments under the experimental conditions mentioned above. For excitation with 735 nm, the detected isosbestic point, which corresponds to the wavelength where the resting and depolarized spectra of OS f cross, was 809.1 5 1.3 nm (n ¼ 5). Such emission spectral behavior at 735 nm excitation can be used for the emission ratiometry. For a more detailed evaluation of the different spectral properties of the OS components, it would be of interest to construct and estimate the spectra of the ICG dye in detail. Eventually, such information would allow for better isolation of the fast and slow components.
In summary, the polarity of the OS fast component could be reversed in different parts of the fluorescence spectrum. In contrast, the polarity of the slow component remained the same throughout the entire range of the spectrum. Accordingly, separating the OS into these components revealed two different mechanisms for the voltage sensitivity of the ICG dye.
The VSDs can be divided into two main groups depending on the fluorescence-changing mechanisms. In the first group of dyes, changes in the membrane potential cause a redistribution of the dye molecules between the lipid and the adjacent phase, whereas when dyes in the second group are inside a lipid, a membrane potential change will cause a change in the orientation and/or position of the charges within the dye molecule. Each of these changes evokes a different voltage-dependent fluorescence property change. The optical response times of the first case are slower than those of the second case.
The change in the OS f polarity at different excitation and emission wavelengths may show the shift of the fluorescent excitation or the emission spectrum of the ICG dye depending on the membrane potential. The voltage-induced spectral shift of the fluorescent dye can be explained by the electrochromism or aggregation of the dye molecules. However, the sensitivity of ICG to the potential caused by aggregation is not reliable because molecular diffusion occurs during this process, which is usually relatively slow. The fast kinetics of the OS f component serves as a basis for assuming that molecular aggregation is not the determining process for the ICG-induced formation of OS f . Furthermore, the fact that we used a quite low dye concentration also suggests that aggregation is not involved. Therefore, it was tempting to speculate that the fast component of the OS, which we measured using the ICG VSD, most likely corresponds to the electrochromic mechanism. FIGURE 4 Change in ICG OS at various excitation and emission wavelengths. (A-D) OS resulting from excitation at 590 nm (yellow), 660 nm (red), 735 nm (cherry), and 780 nm (brown). The fluorescence emission was collected using band-pass filters (see Materials and Methods). The calculated (black) OSs are superimposed on the experimental signals (yellow, red, cherry, and brown), which are given as DF/F in %. The calculated values for the fast (OS f , magenta) versus slow (OS s , gray) OS components at various l ex and l em wavelengths are given in insets. Importantly, to obtain less noisy signals, the data presented here were taken from a 20 Â 20 pixel area during atrial pacing, when there is almost no lateral propagation of the electrical signal.
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Typical electrochromic dyes are amphiphilic substances whose molecules are oriented perpendicular to the surface of the cell membrane (11) . Extremely fast dyes, including the most widely used ANEPPS dyes in the blue-green range, exhibit this type of mechanism. The emission spectra of such dyes are dome shaped, and a change in the membrane potential shifts the spectrum. Thus, depending on where the photon emission is measured relative to the dome, the changes in fluorescence can be positive or negative. It should be noted that such dyes are very effective in situations where ratiometric measurements are used to isolate voltage-dependent fluorescence signals. The fractional change in fluorescence in response to the voltage changes (DF/F) of such dyes generally reaches 10-20% (7).
ICG, as a negatively charged amphiphilic reagent, can act by an electrochromic mechanism. However, in contrast to the well-known electrochromic dyes, the ICG molecule is symmetrical and contains two negative charges, which are located at different ends of the molecule. Therefore, the orientation of ICG molecules in the bilayer lipid membrane should be almost parallel to the membrane surface. Consequently, ICG, similarly to other symmetric polymethine dyes, should have zero dipole moment along its long axis and should not exhibit electrochromism. However, according to the literature (12), the ICG dye has solvatochromic properties. A possible loss of the symmetry of the dipole moment of the dye molecule during an interaction between solvent molecules and the dipole has been proposed, but the exact mechanism underlying the perturbation of charges in the polyamine chain is largely unknown, and there is no consensus regarding that phenomenon (13, 14) .
The NIR polymethine ICG dye (12) was demonstrated to have solvatochromic properties (3,15) ; thus, the dipole moment of the ICG is not zero, and there is evidence to suggest that it will also exhibit electrochromism. Because ICG possesses solvatochromic properties, and because our experiments demonstrated that the OS of the ICG dye contains a voltage-sensitive fast component that responds differently at various excitation and emission wavelengths (see positive and negative waves in Fig. 4) , we can suggest that OS f may be caused by the electrochromic mechanism.
The slow component of ICG may be explained by the ON/OFF mechanism (16) . Negatively charged ICG molecules could move from the extracellular solution into the lipid bilayer as a result of membrane depolarization. However, in this case, the increase in the amount of ICG in the lipids, where the dye quantum yield is higher than in an aqueous solution, should increase the fluorescence intensity during the AP. Nevertheless, in our experiments, as well in an earlier study (2) , the recorded ICG fluorescence intensity of the slow OS decreased. This finding could be the result of the increased concentration of ICG in the lipid phase, leading to dye molecule aggregation, which would cause a corresponding decrease in the fluorescence intensity. A decreased strength of fluorescence due to ICG aggregation is expected only at high dye concentrations. However, in the study by Treger et al. (2) , the dye was removed from the perfusion solution after a few minutes of incubation, whereas in our experiments we injected the dye through a bubble trap by bolus injection (see Materials and Methods), and the final concentration of ICG dye in the perfusion solution was low (~3 mmol/L). Of course, the dye concentration could have been higher near the membrane layer of the external solution than in the bulk solution, but this possibility is hardly sufficient to support the classical ON/OFF fluorescence mechanism or dye aggregation.
Because ICG molecules bind easily to proteins and lipids, it can be assumed that some of the dye is bound to the membrane surface proteins and the other part is localized in the lipid bilayer within the membrane. Changing the membrane potential could cause a repartition of ICG molecules between the two phases of the membrane, thus causing the fluorescence intensity to change. This ICG redeployment between proteins and lipids could explain the minor change in fluorescence intensity during the OAPs. First, molecules that can be redeployed are available in relatively small quantities near the membrane layer. Second, the ICG background fluorescence increases significantly relative to the ICG fluorescence in the water phase when the dye binds to proteins and lipids. Therefore, during ICG redeployment, the fluorescence changes can be relatively small.
ICG OS maps in the heart
Representative activation-time and duration maps of OS 780/800 , OS f , and OS s are presented in Fig. 5 . The maps show no significant difference in the activation time at 50% depolarization for all signals, whereas the duration at 50% repolarization of OS f is shorter (~10 ms) than the durations of the other signals. The activation-time maps (Fig. 5 , upper panels) indicate that OS f and OS s at the same place are different, but the space intervals between the isochrones are almost the same for both components. Therefore, both components can be used to evaluate the process of electrical signal conduction in the myocardium. The slow component is particularly useful for evaluating conduction under pathological conditions, when conduction is slowed.
The parameters of directly recorded signals (i.e., OS 780/800 and AP) and all derivative signals (i.e., OS f , OS s , and OS s(smoothed) ) are presented in Table 1 .
The similar values obtained for the activation time and duration of OS f and the AP support our hypothesis that the fast component represents the real cardiac AP. Naturally, because of the averaging (of OSs from many cells) effect during fluorescence observation using long wavelengths (17) , the upstroke of OS f is flatter than that of the AP.
Finally, in some experiments (n ¼ 5), the K ATP channel agonist pinacidil, which shortens the AP duration, was used to demonstrate the correlations between the ICG OS f and electrical AP (Fig. 6) . Obviously, the curves obtained for the Biophysical Journal 110(3) 723-732 simultaneous recordings of OS f and the electrical AP were highly comparable both under the control conditions (Fig. 6, A and B, magenta versus black) and after the administration of pinacidil (Fig. 6 , B and C, blue versus black). The mean values from five experiments under the control conditions were 155.3 5 3.99 ms and 178.25 5 2.37 ms for OS f versus 155.31 5 3.99 ms and 176.87 5 0.80 ms for the microelectrode-recorded APs evaluated at 50% and 90% of the repolarization, respectively. A similar correlation was obtained after a 10-min perfusion with pinacidil (50 mM), i.e., the AP duration was shortened to 84.8 5 3.02 ms and 114.84 5 4.24 ms, versus 81.85 5 6.94 ms and 111.48 5 7.24 ms for the microelectrode-recorded APs at both repolarization parameters, respectively. The OS s duration, as expected, was longer than the OS f or AP duration, but was similarly shortened by pinacidil, i.e., at 90% of the repolarization, the OS s was shortened from 196.9.0 5 2.12 ms to 156.6.84 5 2.69 ms (n ¼ 5; p < 0.05). Our experiments with pinacidil show that OS f follows the AP changes induced by the pharmacological compound well.
CONCLUSIONS
This study demonstrates that ICG, a fluorescent dye that is widely used to visualize vessels in clinical settings, produces an OS that reflects changes in the membrane potential of the heart. Applying ratiometric and multiplication procedures to OSs obtained at different excitation and emission wavelengths revealed that the OS induced by ICG at characteristic wavelengths, i.e., l ex ¼ 780 nm and l em > 800 nm, is composed of two components: a fast one (OS f ) and a slow one (OS s ). These components differ in their kinetics and their dependence on the fluorescence spectrum. The polarity of OS f changes depending on the spectrum, whereas the polarity of OS s is always negative. The OS with ICG dye can be obtained in a wide spectral range. Importantly, despite the overlap between the two components, the fast component of the ICG fluorescence at all excitation wavelengths was recorded at shorter wavelengths than the slow component.
The voltage-sensitive fluorescence induced by ICG dye in a rabbit heart that was fully stopped was not high compared with the fluorescence of standard voltage-sensitive styryl dyes, such as NIR and ANEPPS dyes. However, after averaging, the good signal/noise ratio (>20 dB) makes the signal suitable for observing cardiac electrical activity. Our data show that a mixture of fast and slow ICG OSs can be used to evaluate the AP activation time and cardiac electrical conduction. For more precise assessments of AP parameters, we recommend utilizing a ratio of two signals obtained at different excitation wavelengths. We believe that this report is an important step toward introducing the use of optical mapping of cardiac electrical activity in the clinic.
Limitations
The use of different excitation and emission wavelengths to measure OS f and OS s is a limitation of this study that should be discussed. Because of the different penetration depths of the light at the tested excitation wavelengths, the OSs were recorded from different depths in the myocardium (18) . The existing transmural gradient of myocardial AP parameters (19, 20) may have an influence on the isolation of these components (i.e., OS f and OS s ). Moreover, it should be mentioned that components calculated using ratiometric and multiplication procedures may differ depending on the pacing stimulus location, because this determines the direction of conduction and may affect the APs of different myocardial layers. In addition, the signals were sequentially recorded by swapping emission filters, i.e., not at the same time.
Another limitation could be related to the calculation of OS s by multiplying two signals recorded at different wavelengths. This type of procedure increases all signals, including those induced by heart wall motion, which would have the same polarity at different wavelengths, as does OS s . Therefore, one should take care to eliminate all motion of the object when calculating OS s by multiplication.
Because mechanical contractions interfere with optical/ electrical signals, we immobilized the hearts by using the uncoupling drugs blebbistatin (21) and BDM (22)-a combination that can minimize motion artifact without affecting AP recordings (23) . Nevertheless, this is the major limitation of using ICG fluorescence for in vivo studies. Change in ICG-induced optical signals at all excitation and emission wavelengths used in the study during atrial pacing in Langendorff-perfused rabbit heart. Change in ICG-induced optical signals at all excitation and emission wavelengths used in the study during endocardial pacing in Langendorff-perfused rabbit heart. 4 
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Figure S3:
Change in ICG-induced optical signals at all excitation and emission wavelengths used in the study during epicardial pacing in Langendorff-perfused rabbit heart.
